David Paul Hesson

USPTO Granted Patents = 7 (Patent Applications = 14)

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 27(Granted Patents)

Company Filing History:

4 out of 4

Clear Creek Bio, Inc.

Integra Lifesciences Corporation

patents

Years Active: 2004-2024

Loading Chart...

7 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12076315 - Stable polymorphic compositions of brequinar sodium and methods of use and manufacture thereof (2024-09-03),

2. 12012383 - Compositions and methods for inhibiting dihydroorotate dehydrogenase (2024-06-18),

3. 11230528 - Compositions and methods for inhibiting dihydroorotate dehydrogenase (2022-01-25),

4. 10889548 - Compositions and methods for inhibiting dihydroorotate dehydrogenase (2021-01-12),

5. 9884899 - Methods for treating fibrosis using CRP antagonists (2018-02-06),

6. 8497243 - Methods and compositions useful in the treatment of mucositis (2013-07-30),

7. 6689756 - Treatment of neurological disease (2004-02-10),

Title: The Innovations of David Paul Hesson: Revolutionizing Therapeutic Compositions

Introduction:

David Paul Hesson, hailing from Malvern, PA (US), is a prolific inventor with 5 patents to his name, showcasing his expertise in the field of pharmaceutical innovations.

Latest Patents:

Hesson's latest patents revolve around therapeutic compositions that inhibit dihydroorotate dehydrogenase (DHODH), aiming to elevate dihydroorotate (DHO) levels in patients. These compositions are particularly beneficial in treating disorders linked to unregulated DHODH activity, notably acute myeloid leukemia. Moreover, the invention includes methods for determining effective doses and the synthesis of potent DHODH inhibitors.

Career Highlights:

Having worked at prominent companies like Promedior, Inc. and Clear Creek Bio, Inc., Hesson has honed his skills and showcased his inventiveness in the realm of pharmaceutical advancements. His contributions have paved the way for novel treatment modalities, especially in the field of oncology.

Collaborations:

Hesson has collaborated with esteemed professionals such as Michael Scott Kramer and Vikram S Kumar, fostering a culture of innovation and knowledge exchange. Through these collaborations, groundbreaking advancements have been achieved in developing therapeutic solutions for challenging medical conditions.

Conclusion:

In conclusion, David Paul Hesson's inventive spirit and dedication to revolutionizing therapeutic compositions underscore his significance in the realm of pharmaceutical innovations. His latest patents stand as a testament to his commitment to improving healthcare outcomes and advancing the field of medicine.

This text is generated by artificial intelligence and may not be accurate.